Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (161-170 of 287) with videos related to

Pageof 29
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Acta Oncologica (Stockholm, Sweden)|February 21, 2019
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registriesCatherine E Mercado, William F Hartsell, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppressionR Charles Nichols, Christopher G Morris, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|December 11, 2013
Hemorrhagic radiation cystitisWilliam M Mendenhall, Randal H Henderson, Joseph A Costa, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicityR Charles Nichols, Thomas J George, Robert A Zaiden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2018
Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship ResearchLisa B Kenney, Zoltan Antal, Jill P Ginsberg, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancerRomaine C Nichols, Soon N Huh, Karl L Prado, et al.
Journal of Hepatocellular Carcinoma|October 1, 2021
Carbon Ion Radiotherapy in the Management of Hepatocellular CarcinomaBelal Abousaida, Danushka Seneviratne, Bradford S Hoppe, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewSujith Baliga, Samir Patel, Issam El Naqa, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Pageof 29

Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Acta Oncologica (Stockholm, Sweden)|February 21, 2019
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registriesCatherine E Mercado, William F Hartsell, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppressionR Charles Nichols, Christopher G Morris, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|December 11, 2013
Hemorrhagic radiation cystitisWilliam M Mendenhall, Randal H Henderson, Joseph A Costa, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicityR Charles Nichols, Thomas J George, Robert A Zaiden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2018
Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship ResearchLisa B Kenney, Zoltan Antal, Jill P Ginsberg, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancerRomaine C Nichols, Soon N Huh, Karl L Prado, et al.
Journal of Hepatocellular Carcinoma|October 1, 2021
Carbon Ion Radiotherapy in the Management of Hepatocellular CarcinomaBelal Abousaida, Danushka Seneviratne, Bradford S Hoppe, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewSujith Baliga, Samir Patel, Issam El Naqa, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Pageof 29